These stocks went in opposite directions in 2019. Will that trend continue this year?
News & Analysis: Cara Therapeutics
These pharma stocks have gone in different directions in the last year, but both hold promise for forward-thinking investors.
Despite their differences, there's a lot of good things going on for both of these health companies.
What does the future look like for this promising biotech stock?
These two companies could be headed in vastly different directions in 2020.
Both of these biotechs could become smash hits, but which is better?
These three small companies have the potential to make you a lot of money.
The remaining weeks of December are chock-full of clinical trial results and FDA approval decisions that savvy investors can take advantage of.
On a tough day on Wall Street, these stocks got hit especially hard.
Investors aren't happy with the company's mixed results from a midstage study of Oral Korsuva.